BAP1 and cancer: Given that BAP1 mutations were always present in the context of monosomy 3, Robertson et al. analyzed cancer cell fractions to estimate the relative timing of BAP1 loss versus monosomy 3 in the TCGA uveal melanoma cohort [17].